Vascular Endothelial Growth Factor (VEGF)-Receptor2: Its Biological Functions, Major Signaling Pathway, and Specific Ligand VEGF-E

REFERENCES

• Alitalo K., Carmeliet P. Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002; 1: 219–227, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Asahara T., Masuda H., Takahashi T., Kalka C., Pastore C., Silver M., Kearne M., Magner M., Isner J. M. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circulation Research 1999; 85: 221–228, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kleckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawlling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435–439, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., Wu Y., Bono F., Devy L., Beck H., Scholz D., Acker T., DiPalma T., Dewerchin M., Noel A., Stalmans I., Barra A., Blacher S., Vandendriessche T., Ponten A., Eriksson U., Plate K. H., Foidart J. M., Schaper W., Charnock-Jones D. S., Hicklin D. J., Herbert J. M., Collen D., Persico M. G. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nature Medicine 2001; 7: 575–583, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cho N. K., Keyes L., Johnson E., Heller J., Ryner L., Karim F., Krasnow M. A. Developmental control of blood cell migration by the Drosophila VEGF pathway. Cell 2002; 108: 865–876, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• De Vries C., Escobedo J. A., Ueno H., Houck K., Ferrara N., Williams L. T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989–991, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Duchek P., Somogyi K., Jekely G., Beccari S., Rorth P. Guidance of cell migration by the Drosophila PDGF/VEGF receptor. Cell 2001; 107: 17–26, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Dvorak H. F. Vascular permeability factor/vascular endothelial growth factor: A critical cytoine in tumor angiogenesis and a potential target for diagnosis and therapy. Journal of Clinical Oncology 2002; 20: 4368–4380, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Eichmann A., Corbel C., Nataf V., Vaigot P., Breant C., Le Douarin N. M. Ligand-dependent development of the endothelial and hemopoietic lineages from embryonic mesodermal cells expressing vascular endothelial growth factor receptor 2. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 5141–5146, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K. S., Powell-Braxton L., Hillan K. J., Moore M. W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439–442, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocrine Reviews 1997; 18: 4–25, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fong G. H., Rossant J., Gertsentein M., Breitman M. L. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376: 66–70, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Fuh G., Li B., Crowley C., Cunningham B., Wells J. A. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor. Journal of Biological Chemistry 1998; 273: 11197–11204, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gasmi A., Bourcier C., Aloui Z., Srairi N., Marchetti S., Gimond C., Wedge S. R., Hennequin L., Pouyssegur J. Complete structure of an increasing capillary permeability protein (ICPP) purified from Vipera lebetina venom. ICPP is angiogenic via vascular endothelial growth factor receptor signalling. Journal of Biological Chemistry 2002; 277: 29992–29998, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gerber H. P., McMurtrey A., Kowalski J., Yan M., Keyt B. A., Dixit V., Ferrara N. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. Journal of Biological Chemistry 1998; 273: 30336–30343, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hanahan D., Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353–364, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Heldin C. H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiological Reviews 1999; 79: 1283–1316, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hirakawa S., Kodama S., Kunstfeld R., Kajiya K., Brown L. F., Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. Journal of Experimental Medicine 2005; 201: 1089–1099, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hiratsuka S., Kataoka Y., Nakao K., Nakamura K., Morikawa S., Tanaka S., Katsuki M., Maru Y., Shibuya M. Vascular endothelial growth factor A (VEGF-A) is involved in guidance of VEGF receptor-positive cells to the anterior portion of early embryos. Molecular and Cellular Biology 2005; 25: 355–363, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., Berlin J., Baron A., Griffing S., Holmgren E., Ferrara N., Fyfe G., Rogers B., Ross R., Kabbinavar F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. New England Journal of Medicine 2004; 350: 2335–2342, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ishimaru S., Ueda R., Hinohara Y., Ohtani M., Hanafusa H. PVR plays a critical role via JNK activation in thorax closure during Drosophila metamorphosis. EMBO Journal 2004; 23: 3984–3994, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO Journal 1996; 15: 290–298, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kaipainen A., Korhonen J., Pajusola K., Aprelikova O., Persico M. G., Terman B. I., Alitalo K. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. Journal of Experimental Medicine 1993; 178: 2077–2088, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kawasaki T., Kitsukawa T., Bekku Y., Matsuda Y., Sanbo M., Yagi T., Fujisawa H. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999; 126: 4895–4902, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Keyt B. A., Nguyen H. V., Berleau L. T., Duarte C. M., Park J., Chen H., Ferrara N. Identification of vascular endothelial growth factor determinanats for binding KDR and FLT-1 receptors. Journal of Biological Chemistry 1996; 271: 5638–5646, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kiba A., Sagara H., Hara T., Shibuya M. VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice. Biochemical and Biophysical Research Communications 2003; 301: 371–377, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kiba A., Yabana N., Shibuya M. A set of loop-1 and -3 structures in the novel VEGF family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling. Journal of Biological Chemistry 2003; 278: 13453–13461, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Larcher F., Murillas R., Bolontrade M., Conti C. J., Jorcano J. L. VEGF/VPF overexpression in skin of transgenic mice induces angiogenesis, vascular hyperpermeability and accelerated tumor development. Oncogene 1998; 17: 303–311, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Luo J. C., Yamaguchi S., Shinkai A., Shitara K., Shibuya M. Significant expression of vascular endothelial growth factor/vascular permeability factor in mouse ascites tumors. Cancer Research 1998; 58: 2652–2660, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Luttun A., Tjwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F., Nagy J. A., Hooper A., Priller J., De Klerck B., Compernolle V., Daci E., Bohlen P., Dewerchin M., Herbert J. M., Fava R., Matthys P., Carmeliet G., Collen D., Dvorak H. F., Hicklin D. J., Carmeliet P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nature Medicine 2002; 8: 831–840, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Lyden D., Hattori K., Dias S., Costa C., Blaikie P., Butros L., Chadburn A., Heissig B., Marks W., Witte L., Wu Y., Hicklin D., Zhu Z., Hackett N. R., Crystal R. G., Moore M. A., Hajjar K. A., Manova K., Benezra R., Rafii S. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Medicine 2001; 7: 1194–1201, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lyttle D. J., Fraser K. M., Fleming S. B., Mercer A. A., Robinson A. J. Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. Journal of Virology 1994; 68: 84–92, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Maes C., Carmeliet P., Moermans K., Stockmans I., Smets N., Collen D., Bouillon R., Carmeliet G. Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. Mechanisms of Development 2002; 111: 61–73, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Matsumoto T., Bohman S., Dixelius J., Berge T., Dimberg A., Magnusson P., Wang L., Wikner C., Qi J. H., Wernstedt C., Wu J., Bruheim S., Mugishima H., Mukhopadhyay D., Spurkland A., Claesson-Welsh L. VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis. EMBO Journal 2005; 24: 2342–2353, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Matsumoto T., Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001; RE21, 2001[CSA]
   Google Scholar
• Matthews W., Jordan C. T., Gavin M., Jenkins N. A., Copeland N. G., Lemischka I. R. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proceedings of the National Academy of Sciences of the United States of America 1991; 88: 9026–9030, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Meyer M., Clauss M., Lepple-Wienhues A., Waltenberger J., Augustin H. G., Ziche M., Lanz C., Buttner M., Rziha H. J., Dehio C. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases. EMBO Journal 1999; 18: 363–374, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N. P.H., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835–846, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Montaldo F., Maffe A., Morini M., Noonan D., Giordano S., Albini A., Prat M. Expression of functional tyrosine kinases on immortalized Kaposi's sarcoma cells. Journal of Cellular Physiology 2000; 184: 246–254, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ogawa S., Oku A., Sawano A., Yamaguchi S., Yazaki Y., Shibuya M. A novel type of vascular endothelial growth factor: VEGF-E (NZ-7 VEGF) preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. Journal of Biological Chemistry 1998; 273: 31273–31282, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Plate K. H., Breier G., Weich H. A., Mennel H. D., Risau W. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. International Journal of Cancer 1994; 59: 520–529, [CSA]
   PubMed Web of Science ®Google Scholar
• Risau W. Mechanism of angiogenesis. Nature 1997; 386: 671–674, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Sakurai Y., Ohgimoto K., Kataoka Y., Yoshida N., Shibuya M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proceedings of the National Academy of Sciences of the United States of America 2005; 102: 1076–1081, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shalaby F., Rossant J., Yamaguchi T. P., Gertsenstein M., Wu X. F., Breitman M. L., Schuh A. C. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995; 376: 62–66, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shay-Salit A., Shushy M., Wolfovitz E., Yahav H., Breviario F., Dejana E., Resnick N. VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 2002; 99: 9462–9467, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shibuya M. Role of VEGF-Flt receptor system in normal and tumor angiogenesis. Advances of Cancer Research 1995; 67: 281–316, [CSA]
   PubMed Web of Science ®Google Scholar
• Shibuya M. Vascular endothelial growth factor receptor family genes: When did the three genes phylogenetically segregate?. Biological Chemistry 2002; 383: 1573–1579, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Shibuya M., Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Experimental Cell Research Dec 3, 2005, Epub ahead of print[CSA]
   PubMed Web of Science ®Google Scholar
• Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990; 5: 519–524, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Shinkai A., Ito M., Anazawa H., Yamaguchi S., Shitara K., Shibuya M. Mapping of the sites involved in ligand-association and dissociation at the extracellular domain of vascular endothelial growth factor receptor KDR. Journal of Biological Chemistry 1998; 273: 31283–31288, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Stupack D. G., Cheresh D. A. Integrins and angiogenesis. Current Topics in Developmental Biology 2004; 64: 207–238, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Takahashi T., Ueno H., Shibuya M. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 1999; 18: 2221–2230, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Takahashi T., Yamaguchi S., Chida K., Shibuya M. A Single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-γ and DNA synthesis in vascular endothelial cells. EMBO Journal 2001; 20: 2768–2778, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Terman B. I., Carrion M. E., Kovacs E., Rasmussen B. A., Eddy R., Shows T. B. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991; 6: 1677–1683, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Veikkola T., Jussila L., Makinen T., Karpanen T., Jeltsch M., Petrova T. V., Kubo H., Thurston G., McDonald D. M., Achen M. G., Stacker S. A., Alitalo K. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice. EMBO Journal 2001; 20: 1223–1231, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wedge S. R., Ogilvie D. J., Dukes M., Kendrew J., Curwen J. O., Hennequin L. F., Thomas A. P., Stokes E. S., Curry B., Richmond G. H., Wadsworth P. F. ZD4190: An orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy. Cancer Research 2000; 60: 970–975, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Wise L. M., Veikkola T., Mercer A. A., Savory L. J., Fleming S. B., Caesar C., Vitali A., Makinen T., Alitalo K., Stacker S. A. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proceedings of the National Academy of Sciences of the United States of America 1999; 96: 3071–3076, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wood J. M., Bold G., Buchdunger E., Cozens R., Ferrari S., Frei J., Hofmann F., Mestan J., Mett H., O'Reilly T., Persohn E., Rosel J., Schnell C., Stover D., Theuer A., Towbin H., Wenger F., Woods-Cook K., Menrad A., Siemeister G., Schirner M., Thierauch K. H., Schneider M. R., Drevs J., Martiny-Baron G., Totzke F. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Research 2000; 60: 2178–2189, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Xia P., Aiello L. P., Ishii H., Jiang Z. Y., Park D. J., Robinson G. S., Takagi H., Newsome W. P., Jirousek M. R., King G. L. Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. Journal of Clinical Investigation 1996; 98: 2018–2026, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Yamashita J., Itoh H., Hirashima M., Ogawa M., Nishikawa S., Yurugi T., Naito M., Nakao K., Nishikawa S. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408: 92–96, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zeng H., Sanyal S., Mukhopadhyay D. Tyrosine residues 951 and 1059 of vascular endothelial growth factor receptor-2 (KDR) are essential for vascular permeability factor/vascular endothelial growth factor-induced endothelium migration and proliferation, respectively. Journal of Biological Chemistry 2001; 276: 32714–32719, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zhao Q., Egashira K., Hiasa K. I., Ishibashi M., Inoue S., Ohtani K., Tan C., Shibuya M., Takeshita A., Sunagawa K. essential role of vascular endothelial growth factor and Flt-1 signals in neointimal formation after periadventitial injury. Arteriosclerosis, Thrombosis, and Vascular Biology 2004; 24: 2284–2289, [INFOTRIEVE], [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar